The KHP CTO quality policy describes the Quality system required to ensure that clinical trials conducted across the Partner Organisations fulfil the statutory requirements laid down in the Medicines for Human Use (Clinical Trials) Regulations.
The aim of the policy is to maintain a quality management process that not only meets the criteria of the Regulations, but also adds value to the Partner Organisations reputations as providers of high quality robust research.
